BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21518758)

  • 21. A Micropolymorphism Altering the Residue Triad 97/114/156 Determines the Relative Levels of Tapasin Independence and Distinct Peptide Profiles for HLA-A(*)24 Allotypes.
    Badrinath S; Kunze-Schumacher H; Blasczyk R; Huyton T; Bade-Doeding C
    J Immunol Res; 2014; 2014():298145. PubMed ID: 25802875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An essential function of tapasin in quality control of HLA-G molecules.
    Park B; Ahn K
    J Biol Chem; 2003 Apr; 278(16):14337-45. PubMed ID: 12582157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of peptide involvement in T cell allorecognition using recombinant HLA class I multimers.
    Whitelegg AM; Oosten LE; Jordan S; Kester M; van Halteren AG; Madrigal JA; Goulmy E; Barber LD
    J Immunol; 2005 Aug; 175(3):1706-14. PubMed ID: 16034111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Limited diversity of peptides related to an alloreactive T cell epitope in the HLA-B27-bound peptide repertoire results from restrictions at multiple steps along the processing-loading pathway.
    Paradela A; Alvarez I; García-Peydró M; Sesma L; Ramos M; Vázquez J; López De Castro JA
    J Immunol; 2000 Jan; 164(1):329-37. PubMed ID: 10605027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Length Distribution of Class I-Restricted T Cell Epitopes Is Determined by Both Peptide Supply and MHC Allele-Specific Binding Preference.
    Trolle T; McMurtrey CP; Sidney J; Bardet W; Osborn SC; Kaever T; Sette A; Hildebrand WH; Nielsen M; Peters B
    J Immunol; 2016 Feb; 196(4):1480-7. PubMed ID: 26783342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Qualitative and quantitative differences in peptides bound to HLA-B27 in the presence of mouse versus human tapasin define a role for tapasin as a size-dependent peptide editor.
    Sesma L; Galocha B; Vázquez M; Purcell AW; Marcilla M; McCluskey J; López de Castro JA
    J Immunol; 2005 Jun; 174(12):7833-44. PubMed ID: 15944288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formation of a major histocompatibility complex class I tapasin disulfide indicates a change in spatial organization of the peptide-loading complex during assembly.
    Chambers JE; Jessop CE; Bulleid NJ
    J Biol Chem; 2008 Jan; 283(4):1862-9. PubMed ID: 18039656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding the obstacle of incompatibility at residue 156 within HLA-B*35 subtypes.
    Manandhar T; Kunze-Schumacher H; Huyton T; Celik AA; Blasczyk R; Bade-Doeding C
    Immunogenetics; 2016 Apr; 68(4):247-60. PubMed ID: 26758079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of adipophilin-specific cytotoxic T lymphocytes using a novel HLA-A2-binding peptide that mediates tumor cell lysis.
    Schmidt SM; Schag K; Müller MR; Weinschenk T; Appel S; Schoor O; Weck MM; Grünebach F; Kanz L; Stevanovic S; Rammensee HG; Brossart P
    Cancer Res; 2004 Feb; 64(3):1164-70. PubMed ID: 14871853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD8 T cell autoreactivity to preproinsulin epitopes with very low human leucocyte antigen class I binding affinity.
    Abreu JR; Martina S; Verrijn Stuart AA; Fillié YE; Franken KL; Drijfhout JW; Roep BO
    Clin Exp Immunol; 2012 Oct; 170(1):57-65. PubMed ID: 22943201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptide microarray-based identification of Mycobacterium tuberculosis epitope binding to HLA-DRB1*0101, DRB1*1501, and DRB1*0401.
    Gaseitsiwe S; Valentini D; Mahdavifar S; Reilly M; Ehrnst A; Maeurer M
    Clin Vaccine Immunol; 2010 Jan; 17(1):168-75. PubMed ID: 19864486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of noncanonical melanoma-associated T cell epitopes for cancer immunotherapy.
    Bredenbeck A; Losch FO; Sharav T; Eichler-Mertens M; Filter M; Givehchi A; Sterry W; Wrede P; Walden P
    J Immunol; 2005 Jun; 174(11):6716-24. PubMed ID: 15905511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of p53 peptides recognized by CD8(+) T lymphocytes from patients with bladder cancer.
    Ferriès E; Connan F; Pagès F; Gaston J; Hagnéré AM; Vieillefond A; Thiounn N; Guillet J; Choppin J
    Hum Immunol; 2001 Aug; 62(8):791-8. PubMed ID: 11476902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel immunodominant peptide presentation strategy: a featured HLA-A*2402-restricted cytotoxic T-lymphocyte epitope stabilized by intrachain hydrogen bonds from severe acute respiratory syndrome coronavirus nucleocapsid protein.
    Liu J; Wu P; Gao F; Qi J; Kawana-Tachikawa A; Xie J; Vavricka CJ; Iwamoto A; Li T; Gao GF
    J Virol; 2010 Nov; 84(22):11849-57. PubMed ID: 20844028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human major histocompatibility complex (MHC) class I molecules with disulfide traps secure disease-related antigenic peptides and exclude competitor peptides.
    Truscott SM; Wang X; Lybarger L; Biddison WE; McBerry C; Martinko JM; Connolly JM; Linette GP; Fremont DH; Hansen TH; Carreno BM
    J Biol Chem; 2008 Mar; 283(12):7480-90. PubMed ID: 18195006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dependence of elevated human leukocyte antigen class I molecule expression on increased heavy chain, light chain (beta 2-microglobulin), transporter associated with antigen processing, tapasin, and peptide.
    Johnson DR; Mook-Kanamori B
    J Biol Chem; 2000 Jun; 275(22):16643-9. PubMed ID: 10748183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Random screening of proteins for HLA-A*0201-binding nine-amino acid peptides is not sufficient for identifying CD8 T cell epitopes recognized in the context of HLA-A*0201.
    Pelte C; Cherepnev G; Wang Y; Schoenemann C; Volk HD; Kern F
    J Immunol; 2004 Jun; 172(11):6783-9. PubMed ID: 15153496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term immunity against actual poxviral HLA ligands as identified by differential stable isotope labeling.
    Meyer VS; Kastenmuller W; Gasteiger G; Franz-Wachtel M; Lamkemeyer T; Rammensee HG; Stevanovic S; Sigurdardottir D; Drexler I
    J Immunol; 2008 Nov; 181(9):6371-83. PubMed ID: 18941228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mass Spectrometric Profiling of HLA-B44 Peptidomes Provides Evidence for Tapasin-Mediated Tryptophan Editing.
    Kaur A; Surnilla A; Zaitouna AJ; Mumphrey MB; Basrur V; Grigorova I; Cieslik M; Carrington M; Nesvizhskii AI; Raghavan M
    J Immunol; 2023 Nov; 211(9):1298-1307. PubMed ID: 37737643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tapasin and human leukocyte antigen class I dysregulation correlates with survival in glioblastoma multiforme.
    Thuring C; Geironson L; Paulsson K
    Anticancer Agents Med Chem; 2014; 14(8):1101-9. PubMed ID: 25175688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.